Global Favipiravir Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 87

Published Date: 06 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Favipiravir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Favipiravir size is estimated to be XX million in 2021 from USD 307.1 million in 2020, with a change of XX% between 2020 and 2021. The global Favipiravir market size is expected to grow at a CAGR of -42.7% for the next five years.

Market segmentation
Favipiravir market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Brand Drug
    Generic Drug

Market segment by Application can be divided into
    Influenza Viruses
    COVID-19
    Others

The key market players for global Favipiravir market are listed below:
    ChemRar Group
    Glenmark
    Fujifilm
    Dr. Reddy
    R-Pharma
    Cipla
    Lupin
    Sun Pharma
    Hisun Pharm

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Favipiravir product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Favipiravir, with price, sales, revenue and global market share of Favipiravir from 2019 to 2021.
Chapter 3, the Favipiravir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Favipiravir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Favipiravir market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Favipiravir sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Favipiravir Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Favipiravir Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Brand Drug
        1.2.3 Generic Drug
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Favipiravir Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Influenza Viruses
        1.3.3 COVID-19
        1.3.4 Others
    1.4 Global Favipiravir Market Size & Forecast
        1.4.1 Global Favipiravir Sales in Value (2016-2026))
        1.4.2 Global Favipiravir Sales in Volume (2016-2026)
        1.4.3 Global Favipiravir Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Favipiravir Production Capacity Analysis
        1.5.1 Global Favipiravir Total Production Capacity (2016-2026)
        1.5.2 Global Favipiravir Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Favipiravir Market Drivers
        1.6.2 Favipiravir Market Restraints
        1.6.3 Favipiravir Trends Analysis

2 Manufacturers Profiles
    2.1 ChemRar Group
        2.1.1 ChemRar Group Details
        2.1.2 ChemRar Group Major Business
        2.1.3 ChemRar Group Favipiravir Product and Services
        2.1.4 ChemRar Group Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Glenmark
        2.2.1 Glenmark Details
        2.2.2 Glenmark Major Business
        2.2.3 Glenmark Favipiravir Product and Services
        2.2.4 Glenmark Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Fujifilm
        2.3.1 Fujifilm Details
        2.3.2 Fujifilm Major Business
        2.3.3 Fujifilm Favipiravir Product and Services
        2.3.4 Fujifilm Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Dr. Reddy
        2.4.1 Dr. Reddy Details
        2.4.2 Dr. Reddy Major Business
        2.4.3 Dr. Reddy Favipiravir Product and Services
        2.4.4 Dr. Reddy Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 R-Pharma
        2.5.1 R-Pharma Details
        2.5.2 R-Pharma Major Business
        2.5.3 R-Pharma Favipiravir Product and Services
        2.5.4 R-Pharma Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Cipla
        2.6.1 Cipla Details
        2.6.2 Cipla Major Business
        2.6.3 Cipla Favipiravir Product and Services
        2.6.4 Cipla Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Lupin
        2.7.1 Lupin Details
        2.7.2 Lupin Major Business
        2.7.3 Lupin Favipiravir Product and Services
        2.7.4 Lupin Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Sun Pharma
        2.8.1 Sun Pharma Details
        2.8.2 Sun Pharma Major Business
        2.8.3 Sun Pharma Favipiravir Product and Services
        2.8.4 Sun Pharma Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Hisun Pharm
        2.9.1 Hisun Pharm Details
        2.9.2 Hisun Pharm Major Business
        2.9.3 Hisun Pharm Favipiravir Product and Services
        2.9.4 Hisun Pharm Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Favipiravir Sales by Manufacturer
    3.1 Global Favipiravir Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Favipiravir Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Favipiravir
    3.4 Market Concentration Rate
        3.4.1 Top 3 Favipiravir Manufacturer Market Share
        3.4.2 Top 6 Favipiravir Manufacturer Market Share
    3.5 Global Favipiravir Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Favipiravir Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Favipiravir Market Size by Region
        4.1.1 Global Favipiravir Sales in Volume by Region (2016-2026)
        4.1.2 Global Favipiravir Revenue by Region (2016-2026)
    4.2 North America Favipiravir Revenue (2016-2026)
    4.3 Europe Favipiravir Revenue (2016-2026)
    4.4 Asia-Pacific Favipiravir Revenue (2016-2026)
    4.5 South America Favipiravir Revenue (2016-2026)
    4.6 Middle East and Africa Favipiravir Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Favipiravir Sales in Volume by Type (2016-2026)
    5.2 Global Favipiravir Revenue by Type (2016-2026)
    5.3 Global Favipiravir Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Favipiravir Sales in Volume by Application (2016-2026)
    6.2 Global Favipiravir Revenue by Application (2016-2026)
    6.3 Global Favipiravir Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Favipiravir Sales by Type (2016-2026)
    7.2 North America Favipiravir Sales by Application (2016-2026)
    7.3 North America Favipiravir Market Size by Country
        7.3.1 North America Favipiravir Sales in Volume by Country (2016-2026)
        7.3.2 North America Favipiravir Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Favipiravir Sales by Type (2016-2026)
    8.2 Europe Favipiravir Sales by Application (2016-2026)
    8.3 Europe Favipiravir Market Size by Country
        8.3.1 Europe Favipiravir Sales in Volume by Country (2016-2026)
        8.3.2 Europe Favipiravir Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Favipiravir Sales by Type (2016-2026)
    9.2 Asia-Pacific Favipiravir Sales by Application (2016-2026)
    9.3 Asia-Pacific Favipiravir Market Size by Region
        9.3.1 Asia-Pacific Favipiravir Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Favipiravir Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Favipiravir Sales by Type (2016-2026)
    10.2 South America Favipiravir Sales by Application (2016-2026)
    10.3 South America Favipiravir Market Size by Country
        10.3.1 South America Favipiravir Sales in Volume by Country (2016-2026)
        10.3.2 South America Favipiravir Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Favipiravir Sales by Type (2016-2026)
    11.2 Middle East & Africa Favipiravir Sales by Application (2016-2026)
    11.3 Middle East & Africa Favipiravir Market Size by Country
        11.3.1 Middle East & Africa Favipiravir Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Favipiravir Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Favipiravir Typical Distributors
    12.3 Favipiravir Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Favipiravir Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Favipiravir Revenue by Application, (USD Million), 2021-2026
    Table 3. ChemRar Group Basic Information, Manufacturing Base and Competitors
    Table 4. ChemRar Group Major Business
    Table 5. ChemRar Group Favipiravir Product and Services
    Table 6. ChemRar Group Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Glenmark Basic Information, Manufacturing Base and Competitors
    Table 8. Glenmark Major Business
    Table 9. Glenmark Favipiravir Product and Services
    Table 10. Glenmark Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Fujifilm Basic Information, Manufacturing Base and Competitors
    Table 12. Fujifilm Major Business
    Table 13. Fujifilm Favipiravir Product and Services
    Table 14. Fujifilm Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Dr. Reddy Basic Information, Manufacturing Base and Competitors
    Table 16. Dr. Reddy Major Business
    Table 17. Dr. Reddy Favipiravir Product and Services
    Table 18. Dr. Reddy Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. R-Pharma Basic Information, Manufacturing Base and Competitors
    Table 20. R-Pharma Major Business
    Table 21. R-Pharma Favipiravir Product and Services
    Table 22. R-Pharma Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Cipla Basic Information, Manufacturing Base and Competitors
    Table 24. Cipla Major Business
    Table 25. Cipla Favipiravir Product and Services
    Table 26. Cipla Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Lupin Basic Information, Manufacturing Base and Competitors
    Table 28. Lupin Major Business
    Table 29. Lupin Favipiravir Product and Services
    Table 30. Lupin Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Sun Pharma Basic Information, Manufacturing Base and Competitors
    Table 32. Sun Pharma Major Business
    Table 33. Sun Pharma Favipiravir Product and Services
    Table 34. Sun Pharma Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Hisun Pharm Basic Information, Manufacturing Base and Competitors
    Table 36. Hisun Pharm Major Business
    Table 37. Hisun Pharm Favipiravir Product and Services
    Table 38. Hisun Pharm Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Global Favipiravir Sales by Manufacturer (2019-2021e) & (K Units)
    Table 40. Global Favipiravir Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 41. Market Position of Manufacturers in Favipiravir, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 42. Global Favipiravir Production Capacity by Company, (K Units): 2020 VS 2021
    Table 43. Head Office and Favipiravir Production Site of Key Manufacturer
    Table 44. Favipiravir New Entrant and Capacity Expansion Plans
    Table 45. Favipiravir Mergers & Acquisitions in the Past Five Years
    Table 46. Global Favipiravir Sales by Region (2016-2021e) & (K Units)
    Table 47. Global Favipiravir Sales by Region (2021-2026) & (K Units)
    Table 48. Global Favipiravir Revenue by Region (2016-2021e) & (USD Million)
    Table 49. Global Favipiravir Revenue by Region (2021-2026) & (USD Million)
    Table 50. Global Favipiravir Sales by Type (2016-2021e) & (K Units)
    Table 51. Global Favipiravir Sales by Type (2021-2026) & (K Units)
    Table 52. Global Favipiravir Revenue by Type (2016-2021e) & (USD Million)
    Table 53. Global Favipiravir Revenue by Type (2021-2026) & (USD Million)
    Table 54. Global Favipiravir Price by Type (2016-2021e) & (US$/Unit)
    Table 55. Global Favipiravir Price by Type (2021-2026) & (US$/Unit)
    Table 56. Global Favipiravir Sales by Application (2016-2021e) & (K Units)
    Table 57. Global Favipiravir Sales by Application (2021-2026) & (K Units)
    Table 58. Global Favipiravir Revenue by Application (2016-2021e) & (USD Million)
    Table 59. Global Favipiravir Revenue by Application (2021-2026) & (USD Million)
    Table 60. Global Favipiravir Price by Application (2016-2021e) & (US$/Unit)
    Table 61. Global Favipiravir Price by Application (2021-2026) & (US$/Unit)
    Table 62. North America Favipiravir Sales by Country (2016-2021e) & (K Units)
    Table 63. North America Favipiravir Sales by Country (2021-2026) & (K Units)
    Table 64. North America Favipiravir Revenue by Country (2016-2021e) & (USD Million)
    Table 65. North America Favipiravir Revenue by Country (2021-2026) & (USD Million)
    Table 66. North America Favipiravir Sales by Type (2016-2021e) & (K Units)
    Table 67. North America Favipiravir Sales by Type (2021-2026) & (K Units)
    Table 68. North America Favipiravir Sales by Application (2016-2021e) & (K Units)
    Table 69. North America Favipiravir Sales by Application (2021-2026) & (K Units)
    Table 70. Europe Favipiravir Sales by Country (2016-2021e) & (K Units)
    Table 71. Europe Favipiravir Sales by Country (2021-2026) & (K Units)
    Table 72. Europe Favipiravir Revenue by Country (2016-2021e) & (USD Million)
    Table 73. Europe Favipiravir Revenue by Country (2021-2026) & (USD Million)
    Table 74. Europe Favipiravir Sales by Type (2016-2021e) & (K Units)
    Table 75. Europe Favipiravir Sales by Type (2021-2026) & (K Units)
    Table 76. Europe Favipiravir Sales by Application (2016-2021e) & (K Units)
    Table 77. Europe Favipiravir Sales by Application (2021-2026) & (K Units)
    Table 78. Asia-Pacific Favipiravir Sales by Region (2016-2021e) & (K Units)
    Table 79. Asia-Pacific Favipiravir Sales by Region (2021-2026) & (K Units)
    Table 80. Asia-Pacific Favipiravir Revenue by Region (2016-2021e) & (USD Million)
    Table 81. Asia-Pacific Favipiravir Revenue by Region (2021-2026) & (USD Million)
    Table 82. Asia-Pacific Favipiravir Sales by Type (2016-2021e) & (K Units)
    Table 83. Asia-Pacific Favipiravir Sales by Type (2021-2026) & (K Units)
    Table 84. Asia-Pacific Favipiravir Sales by Application (2016-2021e) & (K Units)
    Table 85. Asia-Pacific Favipiravir Sales by Application (2021-2026) & (K Units)
    Table 86. South America Favipiravir Sales by Country (2016-2021e) & (K Units)
    Table 87. South America Favipiravir Sales by Country (2021-2026) & (K Units)
    Table 88. South America Favipiravir Revenue by Country (2016-2021e) & (USD Million)
    Table 89. South America Favipiravir Revenue by Country (2021-2026) & (USD Million)
    Table 90. South America Favipiravir Sales by Type (2016-2021e) & (K Units)
    Table 91. South America Favipiravir Sales by Type (2021-2026) & (K Units)
    Table 92. South America Favipiravir Sales by Application (2016-2021e) & (K Units)
    Table 93. South America Favipiravir Sales by Application (2021-2026) & (K Units)
    Table 94. Middle East & Africa Favipiravir Sales by Country (2016-2021e) & (K Units)
    Table 95. Middle East & Africa Favipiravir Sales by Country (2021-2026) & (K Units)
    Table 96. Middle East & Africa Favipiravir Revenue by Country (2016-2021e) & (USD Million)
    Table 97. Middle East & Africa Favipiravir Revenue by Country (2021-2026) & (USD Million)
    Table 98. Middle East & Africa Favipiravir Sales by Type (2016-2021e) & (K Units)
    Table 99. Middle East & Africa Favipiravir Sales by Type (2021-2026) & (K Units)
    Table 100. Middle East & Africa Favipiravir Sales by Application (2016-2021e) & (K Units)
    Table 101. Middle East & Africa Favipiravir Sales by Application (2021-2026) & (K Units)
    Table 102. Direct Channel Pros & Cons
    Table 103. Indirect Channel Pros & Cons
    Table 104. Favipiravir Typical Distributors
    Table 105. Favipiravir Typical Customers
List of Figures
    Figure 1. Favipiravir Picture
    Figure 2. Global Favipiravir Sales Market Share by Type in 2020
    Figure 3. Brand Drug
    Figure 4. Generic Drug
    Figure 5. Global Favipiravir Sales Market Share by Application in 2020
    Figure 6. Influenza Viruses
    Figure 7. COVID-19
    Figure 8. Others
    Figure 9. Global Favipiravir Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 10. Global Favipiravir Market Size and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Favipiravir Sales (2016-2026) & (K Units)
    Figure 12. Global Favipiravir Price by Type (2016-2026) & (US$/Unit)
    Figure 13. Global Favipiravir Production Capacity (2016-2026) & (K Units)
    Figure 14. Global Favipiravir Production Capacity by Geographic Region: 2020 VS 2021
    Figure 15. Favipiravir Market Drivers
    Figure 16. Favipiravir Market Restraints
    Figure 17. Favipiravir Market Trends
    Figure 18. Global Favipiravir Sales Market Share by Manufacturer in 2020
    Figure 19. Global Favipiravir Revenue Market Share by Manufacturer in 2020
    Figure 20. Favipiravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 21. Top 3 Favipiravir Manufacturer (Revenue) Market Share in 2020
    Figure 22. Top 6 Favipiravir Manufacturer (Revenue) Market Share in 2020
    Figure 23. Global Favipiravir Sales Market Share by Region (2016-2026)
    Figure 24. Global Favipiravir Revenue Market Share by Region (2016-2026)
    Figure 25. North America Favipiravir Revenue (2016-2026) & (USD Million)
    Figure 26. Europe Favipiravir Revenue (2016-2026) & (USD Million)
    Figure 27. Asia-Pacific Favipiravir Revenue (2016-2026) & (USD Million)
    Figure 28. South America Favipiravir Revenue (2016-2026) & (USD Million)
    Figure 29. Middle East & Africa Favipiravir Revenue (2016-2026) & (USD Million)
    Figure 30. Global Favipiravir Sales Market Share by Type (2016-2026)
    Figure 31. Global Favipiravir Revenue Market Share by Type (2016-2026)
    Figure 32. Global Favipiravir Price by Type (2016-2026) & (US$/Unit)
    Figure 33. Global Favipiravir Sales Market Share by Application (2016-2026)
    Figure 34. Global Favipiravir Revenue Market Share by Application (2016-2026)
    Figure 35. Global Favipiravir Price by Application (2016-2026) & (US$/Unit)
    Figure 36. North America Favipiravir Sales Market Share by Type (2016-2026)
    Figure 37. North America Favipiravir Sales Market Share by Application (2016-2026)
    Figure 38. North America Favipiravir Sales Market Share by Country (2016-2026)
    Figure 39. North America Favipiravir Revenue Market Share by Country (2016-2026)
    Figure 40. United States Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 41. Canada Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Mexico Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Europe Favipiravir Sales Market Share by Type (2016-2026)
    Figure 44. Europe Favipiravir Sales Market Share by Application (2016-2026)
    Figure 45. Europe Favipiravir Sales Market Share by Country (2016-2026)
    Figure 46. Europe Favipiravir Revenue Market Share by Country (2016-2026)
    Figure 47. Germany Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. France Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. United Kingdom Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Russia Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Italy Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Asia-Pacific Favipiravir Sales Market Share by Region (2016-2026)
    Figure 53. Asia-Pacific Favipiravir Sales Market Share by Application (2016-2026)
    Figure 54. Asia-Pacific Favipiravir Sales Market Share by Region (2016-2026)
    Figure 55. Asia-Pacific Favipiravir Revenue Market Share by Region (2016-2026)
    Figure 56. China Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Japan Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Korea Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. India Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Southeast Asia Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Australia Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. South America Favipiravir Sales Market Share by Type (2016-2026)
    Figure 63. South America Favipiravir Sales Market Share by Application (2016-2026)
    Figure 64. South America Favipiravir Sales Market Share by Country (2016-2026)
    Figure 65. South America Favipiravir Revenue Market Share by Country (2016-2026)
    Figure 66. Brazil Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Argentina Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Middle East & Africa Favipiravir Sales Market Share by Type (2016-2026)
    Figure 69. Middle East & Africa Favipiravir Sales Market Share by Application (2016-2026)
    Figure 70. Middle East & Africa Favipiravir Sales Market Share by Country (2016-2026)
    Figure 71. Middle East & Africa Favipiravir Revenue Market Share by Country (2016-2026)
    Figure 72. Turkey Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Egypt Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Saudi Arabia Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. South Africa Favipiravir Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Sales Channel: Direct Channel vs Indirect Channel
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm

Related Reports

Global Favipiravir Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Favipiravir Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 08 Jan 2022

date Pharma & Healthcare

The Favipiravir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Favipiravir Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Favipiravir Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.

Global Favipiravir Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Favipiravir Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Favipiravir market size was valued at USD 352.7 million in 2023 and is forecast to a readjusted size of USD 67 million by 2030 with a CAGR of -21.1% during review period.

Global Favipiravir Supply, Demand and Key Producers, 2024-2030

Global Favipiravir Supply, Demand and Key Producers, 2024-2030

date 27 Feb 2024

date Pharma & Healthcare

The global Favipiravir market size is expected to reach $ 67 million by 2030, rising at a market growth of -21.1% CAGR during the forecast period (2024-2030).

Product Tags

favipiravir

favipiravir tablets

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>